Literature DB >> 27002858

Comparisons of Cocaine-Only, Opioid-Only, and Users of Both Substances in the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC).

Robert F Leeman1, Qisi Sun2, Devorah Bogart3, Cheryl L Beseler4, Mehmet Sofuoglu1.   

Abstract

BACKGROUND: Cocaine and opioid co-use is a notable public health concern, but little is known about correlates of this behavior. Most prior findings come from treatment samples and concern cocaine and heroin. Findings from a nationally representative sample involving primarily prescription opioid misuse would expand knowledge.
METHODS: Past-12-month cocaine and/or opioid users in Wave 1 of the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC) formed the sample (N = 839). Cocaine-only, opioid-only, and cocaine/opioid co-users were compared regarding sociodemographics, other substance involvement, psychiatric, and medical conditions/events.
RESULTS: Opioid-only users were the largest group (n = 622), followed by cocaine-only (n = 144) and co-users (n = 73). The vast majority of opioid misuse was of prescription opioids (1.4% with past-12-month use of heroin). Notably, co-users did not differ from single drug users in frequency of use of either drug. Co-users did not have significantly greater incidence of any psychiatric conditions, medial conditions, or events. In preliminary analyses, co-users were more likely than either single use group to report several classes of other drug use. However, for most comparisons, opioid use did not add substantial risk beyond cocaine use. Differences on multiple sociodemographic variables suggested opioid-only users were at lowest risk of negative outcomes. These results may relate to a finding that opioid-only users were less likely to have sought treatment. CONCLUSIONS/IMPORTANCE: This sample of past-12-month cocaine and/or opioid users had greater involvement with other substances, more psychiatric and medical conditions compared to the general population. Co-users had greater involvement with other substances than opioid-only users in particular.

Entities:  

Keywords:  Cocaine; alcohol use disorder; cannabis; comorbidity; epidemiology; help-seeking; heroin; nicotine; opioid; poly-substance use

Mesh:

Year:  2016        PMID: 27002858      PMCID: PMC5097614          DOI: 10.3109/10826084.2015.1122063

Source DB:  PubMed          Journal:  Subst Use Misuse        ISSN: 1082-6084            Impact factor:   2.164


  36 in total

1.  Prediction of relapse to frequent heroin use and the role of methadone prescription: an analysis of the Amsterdam Cohort Study among drug users.

Authors:  Fabian Termorshuizen; Anneke Krol; Maria Prins; Ronald Geskus; Wim van den Brink; Erik J C van Ameijden
Journal:  Drug Alcohol Depend       Date:  2005-02-24       Impact factor: 4.492

2.  Buprenorphine treatment outcomes among opioid-dependent cocaine users and non-users.

Authors:  Chinazo O Cunningham; Angela Giovanniello; Hillary V Kunins; Robert J Roose; Aaron D Fox; Nancy L Sohler
Journal:  Am J Addict       Date:  2013 Jul-Aug

3.  Sustained release d-amphetamine reduces cocaine but not 'speedball'-seeking in buprenorphine-maintained volunteers: a test of dual-agonist pharmacotherapy for cocaine/heroin polydrug abusers.

Authors:  Mark K Greenwald; Leslie H Lundahl; Caren L Steinmiller
Journal:  Neuropsychopharmacology       Date:  2010-09-29       Impact factor: 7.853

Review 4.  Opioid epidemic in the United States.

Authors:  Laxmaiah Manchikanti; Standiford Helm; Bert Fellows; Jeffrey W Janata; Vidyasagar Pampati; Jay S Grider; Mark V Boswell
Journal:  Pain Physician       Date:  2012-07       Impact factor: 4.965

5.  Mood and anxiety disorders and their association with non-medical prescription opioid use and prescription opioid-use disorder: longitudinal evidence from the National Epidemiologic Study on Alcohol and Related Conditions.

Authors:  S S Martins; M C Fenton; K M Keyes; C Blanco; H Zhu; C L Storr
Journal:  Psychol Med       Date:  2011-10-17       Impact factor: 7.723

6.  Gender and comorbidity among individuals with opioid use disorders in the NESARC study.

Authors:  Christine E Grella; Mitchell P Karno; Umme S Warda; Noosha Niv; Alison A Moore
Journal:  Addict Behav       Date:  2009-01-30       Impact factor: 3.913

7.  The effect of baseline cocaine use on treatment outcomes for heroin dependence over 24 months: findings from the Australian Treatment Outcome Study.

Authors:  Anna Williamson; Shane Darke; Joanne Ross; Maree Teesson
Journal:  J Subst Abuse Treat       Date:  2007-02-22

8.  The Alcohol Use Disorder and Associated Disabilities Interview Schedule-IV (AUDADIS-IV): reliability of alcohol consumption, tobacco use, family history of depression and psychiatric diagnostic modules in a general population sample.

Authors:  Bridget F Grant; Deborah A Dawson; Frederick S Stinson; Patricia S Chou; Ward Kay; Roger Pickering
Journal:  Drug Alcohol Depend       Date:  2003-07-20       Impact factor: 4.492

9.  Probability and predictors of transition from abuse to dependence on alcohol, cannabis, and cocaine: results from the National Epidemiologic Survey on Alcohol and Related Conditions.

Authors:  Ludwing Flórez-Salamanca; Roberto Secades-Villa; Deborah S Hasin; Linda Cottler; Shuai Wang; Bridget F Grant; Carlos Blanco
Journal:  Am J Drug Alcohol Abuse       Date:  2013-05       Impact factor: 3.829

10.  Substance use disorders and adoption: findings from a national sample.

Authors:  Gihyun Yoon; Joseph Westermeyer; Marion Warwick; Michael A Kuskowski
Journal:  PLoS One       Date:  2012-11-15       Impact factor: 3.240

View more
  13 in total

1.  Escalation of drug use in persons dually diagnosed with opioid and cocaine dependence: Gender comparison and dimensional predictors.

Authors:  Eduardo R Butelman; Carina Y Chen; Kate G Brown; Mary Jeanne Kreek
Journal:  Drug Alcohol Depend       Date:  2019-10-22       Impact factor: 4.492

2.  Prescription Opioid Misuse in US Older Adults: Associated Comorbidities and Reduced Quality of Life in the National Epidemiologic Survey of Alcohol and Related Conditions-III.

Authors:  Ty S Schepis; Sean Esteban McCabe
Journal:  J Clin Psychiatry       Date:  2019-11-19       Impact factor: 4.384

3.  Bidirectional influence of heroin and cocaine escalation in persons with dual opioid and cocaine dependence diagnoses.

Authors:  Eduardo R Butelman; Carina Y Chen; Kimberly J Lake; Kate G Brown; Mary Jeanne Kreek
Journal:  Exp Clin Psychopharmacol       Date:  2020-10-29       Impact factor: 3.157

Review 4.  The Cholinergic System as a Treatment Target for Opioid Use Disorder.

Authors:  Kevin P Jensen; Elise E DeVito; Sarah Yip; Kathleen M Carroll; Mehmet Sofuoglu
Journal:  CNS Drugs       Date:  2018-11       Impact factor: 5.749

Review 5.  Medications for substance use disorders (SUD): emerging approaches.

Authors:  Eduardo R Butelman; Mary Jeanne Kreek
Journal:  Expert Opin Emerg Drugs       Date:  2017-10-30       Impact factor: 4.191

6.  Pharmacotherapy for Cocaine Use Disorder-a Systematic Review and Meta-analysis.

Authors:  Brian Chan; Karli Kondo; Michele Freeman; Chelsea Ayers; Jessica Montgomery; Devan Kansagara
Journal:  J Gen Intern Med       Date:  2019-06-10       Impact factor: 5.128

7.  Identifying Clinical Risk Factors for Opioid Use Disorder using a Distributed Algorithm to Combine Real-World Data from a Large Clinical Data Research Network.

Authors:  Jiayi Tong; Zhaoyi Chen; Rui Duan; Wei-Hsuan Lo-Ciganic; Tianchen Lyu; Cui Tao; Peter A Merkel; Henry R Kranzler; Jiang Bian; Yong Chen
Journal:  AMIA Annu Symp Proc       Date:  2021-01-25

8.  Rethinking the Use of "Polysubstance" to Describe Complex Substance Use Patterns.

Authors:  Riley D Shearer; Gavin Bart; Charles Reznikoff
Journal:  J Gen Intern Med       Date:  2022-02-02       Impact factor: 6.473

9.  A latent class analysis of the past-30-day substance use patterns among lifetime cocaine users: Findings from a community sample in North Central Florida.

Authors:  Yiyang Liu; Amy L Elliott; Mirsada Serdarevic; Robert F Leeman; Linda B Cottler
Journal:  Addict Behav Rep       Date:  2019-02-14

10.  Non-medical Cannabis Self-Exposure as a Dimensional Predictor of Opioid Dependence Diagnosis: A Propensity Score Matched Analysis.

Authors:  Eduardo R Butelman; Angelo G I Maremmani; Silvia Bacciardi; Carina Y Chen; Joel Correa da Rosa; Mary Jeanne Kreek
Journal:  Front Psychiatry       Date:  2018-06-27       Impact factor: 4.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.